159 results on '"Gonska, Birgid"'
Search Results
2. Combined Computed Coronary Tomography Angiography and Transcatheter Aortic Valve Implantation (TAVI) Planning Computed Tomography Reliably Detects Relevant Coronary Artery Disease Pre-TAVI.
3. Significant Differences in Debris Captured by the Sentinel Dual-Filter Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Among Different Valve Types
4. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis
5. Drug-coated balloon: an effective alternative to stent strategy in small-vessel coronary artery disease—a meta-analysis
6. Cardiac magnetic resonance imaging for preprocedural planning of percutaneous left atrial appendage closure
7. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures
8. Outcome of Patients with Mixed Aortic Valve Disease Undergoing Transfemoral Aortic Valve Replacement
9. Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement
10. Cusp-overlap view reduces conduction disturbances and permanent pacemaker implantation after transcatheter aortic valve replacement even with balloon-expandable and mechanically-expandable heart valves.
11. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome
12. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation
13. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve
14. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve
15. Computed tomography angiography/magnetic resonance imaging-based preprocedural planning and guidance in the interventional treatment of structural heart disease
16. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk
17. Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation
18. Case Report: Myocarditis After COVID-19 Vaccination - Case Series and Literature Review
19. Case Report: Myocarditis After COVID-19 Vaccination – Case Series and Literature Review
20. Imaging Challenges in Patients with Severe Aortic Stenosis and Heart Failure: Did We Find a Way Out of the Labyrinth?
21. Vascular Access Site Complications Do Not Correlate With Large Sheath Diameter in TAVI Procedures With New Generation Devices
22. Impact of extent of coronary artery disease and percutaneous revascularization assessed by the SYNTAX score on outcomes following transcatheter aortic valve replacement
23. The Predictive Value of Right Ventricular Longitudinal Strain in Pulmonary Hypertension, Heart Failure, and Valvular Diseases
24. Vascular access site complications do not correlate with large sheath diameter in TAVI procedures with new generation devices
25. Additional file 1 of Impact of extent of coronary artery disease and percutaneous revascularization assessed by the SYNTAX score on outcomes following transcatheter aortic valve replacement
26. The Prognostic Importance of Right Ventricular Longitudinal Strain in Patients with Cardiomyopathies, Connective Tissue Diseases, Coronary Artery Disease, and Congenital Heart Diseases
27. Vascular Access-Site Choice and Outcomes in Patients With Previous Coronary Artery Bypass Surgery Undergoing Coronary Catheterization in a High-Volume Transradial Center.
28. Long-term clinical outcome of persistent left bundle branch block after transfemoral aortic valve implantation
29. TCT-4 Reduction of stroke with use of the double-filter cerebral embolic protection device in patients undergoing transfemoral aortic valve replacement with self-expandable, mechanically implantable and balloon-expandable aortic valves
30. TCT-628 Impact of prestaged percutaneous coronary intervention on outcome in coronary artery disease patients undergoing transfemoral aortic valve replacement
31. Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
32. Author's reply
33. Predictors of permanent pacemaker implantation after transfemoral aortic valve implantation with the Lotus valve
34. TCT-35 Cerebral embolic protection during transfemoral aortic valve replacement reduces death and stroke compared to unprotected procedure in all subgroups
35. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome
36. The balloon-expandable Edwards Sapien 3 valve is superior to the self-expanding Medtronic CoreValve in patients with severe aortic stenosis undergoing transfemoral aortic valve implantation
37. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement
38. ONE YEAR OUTCOME IN PATIENTS UNDERGOING TRANSFEMORAL AORTIC VALVE REPLACEMENT (TAVR) WITH THE REPOSITIONABLE AND RETRIEVABLE BOSTON SCIENTIFIC LOTUS VALVE COMPARED WITH THE BALLOON-EXPANDABLE EDWARDS SAPIEN 3 DEVICE
39. SIGNIFICANT REDUCTION OF CEREBRAL ISCHEMIC EVENTS WITH THE SENTINEL CEREBRAL EMBOLI PROTECTION DEVICE IN PATIENTS WITH TRANSCATHETER AORTIC VALVE REPLACEMENT
40. APIXABAN IN ATRIAL FIBRILLATION PATIENTS WITH RENAL INSUFFICIENCY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
41. Long‐term clinical outcome of persistent left bundle branch block after transfemoral aortic valve implantation.
42. TCT-663 Twelve months outcome in patients undergoing transfemoral aortic valve replacement (TAVR) with the repositionable and retrievable Boston Scientific Lotus valve compared with the balloon-expandable Edwards Sapien 3 device
43. TCT-636 Percutaneous mitral valve repair in primary compared with secondary mitral valve regurgitation using the Mitral Valve Academic Research Consortium criteria
44. TCT-744 New generation devices for transfemoral transcatheter aortic valve replacement (Boston Scientific Lotus Valve and Edwards Sapien 3) are superior compared with last generation devices (Edwards XT and Medtronic Corevalve) with respect to VARC-2 outcome
45. TCT-690 Influence of calcium, implantation depth and oversizing on the occurrence of conduction disturbances and need for pacemaker implantation after implantation of the balloon-expandable Edwards Sapien 3 valve
46. Transfemoral aortic valve implantation with the repositionable Lotus valve for treatment of patients with symptomatic severe aortic stenosis: results from a single-centre experience
47. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve
48. TRANSFEMORAL AORTIC VALVE IMPLANTATION WITH THE NEW EDWARDS SAPIEN 3 VALVE FOR TREATMENT OF SEVERE AORTIC STENOSIS
49. Transfemoral Aortic Valve Implantation with the New Edwards Sapien 3 Valve for Treatment of Severe Aortic Stenosis—Impact of Valve Size in a Single Center Experience
50. CRT-400.26 Transfemoral Aortic Valve Implantation in Patients With Symptomatic Severe Aortic Stenosis With the Repositionable Lotus Valve: Results From a High Volume Center
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.